XML 33 R23.htm IDEA: XBRL DOCUMENT v3.22.4
FINANCIAL INSTRUMENTS (Tables)
 6 Months Ended
Dec. 31, 2022
Investments, All Other Investments [Abstract]  
SCHEDULE OF CASH AND CASH EQUIVALENTS AND INVESTMENTS

   As of December 31, 2022 
   Cost   Unrealized Gain (Loss)   Fair Value   Cash and Cash Equivalents   Investments 
Cash  $611,626   $-       $611,626     
Level 1:                         
Money market funds   6,593,096    -    6,593,096    6,593,096     
Total cash and cash equivalents  $7,204,722   $-   $6,593,096   $7,204,722      
                          
Level 1:                         
Investments  $241,595   $(5,019)  $236,576        $236,576 

 

   As of June 30, 2022 
   Cost   Unrealized Gain (Loss)   Fair Value   Cash and Cash Equivalents   Investments 
Cash  $1,233,608   $-       $1,233,608     
Level 1:                         
Money market funds   15,016,058    -    15,016,058    15,016,058     
Total cash and cash equivalents  $16,249,666   $-   $15,016,058   $16,249,666      
                          
Level 1:                         
Investments  $245,187   $(5,873)  $239,314        $239,314 
SCHEDULE OF FAIR VALUE OF CONTINGENT CONSIDERATION

As of December 31, 2022, the Company’s contingent consideration liabilities current and non-current balances were as follows:

 

                     
   As of December 31, 2022 
   Contingent Consideration at Purchase Date   Changes in Fair Value   Fair Value   Contingent Consideration 
Level 3:                    
Contingent consideration, current - S5D  $2,060,300   $(1,437,000)  $623,300   $623,300 
Contingent consideration, current - BLI   1,841,100    (870,700)   970,400    970,400 
Total contingent consideration, current portion  $3,901,400   $(2,307,700)  $1,593,700   $1,593,700 
                     
Level 3:                    
Contingent consideration, non-current - S5D  $7,108,900   $(2,238,400)  $4,870,500   $4,870,500 
Contingent consideration, non-current - BLI   4,297,900    (707,300)   3,590,600    3,590,600 
Total contingent consideration, net of current portion  $11,406,800   $(2,945,700)  $8,461,100   $8,461,100 
 

As of June 30, 2022, the Company’s contingent consideration liabilities current and non-current balances were as follows:

 

                     
   As of June 30, 2022 
   Contingent Consideration at Purchase Date   Changes in Fair Value   Fair Value   Contingent Consideration 
Level 3:                
Contingent consideration, current - S5D  $2,060,300   $(662,700)  $1,397,600   $1,397,600 
Contingent consideration, current - AUGGD   -    568,571    568,571    568,571 
Total contingent consideration, current  $2,060,300   $(94,129)  $1,966,171   $1,966,171 
                     
Level 3:                    
Contingent consideration, non-current - S5D  $7,108,900   $(1,768,100)  $5,340,800   $5,340,800